Clinical Trial Update: Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining luteal supplementation with recombinant LH after GnRH-agonist triggering in IVF; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• recombinant human luteinizing hormone (Rec-LH) (lutropin alfa)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Pregnancy, Pregnancy Loss | Phase 4 | Status: UNKNOWN